Bank of New York Mellon’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $963K | Buy |
187,997
+74,764
| +66% | +$383K | ﹤0.01% | 3131 |
|
2025
Q1 | $155K | Buy |
113,233
+10,213
| +10% | +$14K | ﹤0.01% | 3920 |
|
2024
Q4 | $318K | Sell |
103,020
-8,715
| -8% | -$26.9K | ﹤0.01% | 3730 |
|
2024
Q3 | $860K | Sell |
111,735
-29,888
| -21% | -$230K | ﹤0.01% | 3215 |
|
2024
Q2 | $1.22M | Buy |
141,623
+15,373
| +12% | +$132K | ﹤0.01% | 3077 |
|
2024
Q1 | $1M | Sell |
126,250
-14,718
| -10% | -$117K | ﹤0.01% | 3144 |
|
2023
Q4 | $1.4M | Sell |
140,968
-13,705
| -9% | -$136K | ﹤0.01% | 3005 |
|
2023
Q3 | $1.74M | Buy |
154,673
+13,418
| +9% | +$151K | ﹤0.01% | 2889 |
|
2023
Q2 | $469K | Sell |
141,255
-149
| -0.1% | -$495 | ﹤0.01% | 3626 |
|
2023
Q1 | $559K | Sell |
141,404
-4,947
| -3% | -$19.5K | ﹤0.01% | 3437 |
|
2022
Q4 | $1.06M | Sell |
146,351
-1,845
| -1% | -$13.4K | ﹤0.01% | 3166 |
|
2022
Q3 | $537K | Buy |
148,196
+13,812
| +10% | +$50K | ﹤0.01% | 3530 |
|
2022
Q2 | $608K | Buy |
134,384
+109,163
| +433% | +$494K | ﹤0.01% | 3465 |
|
2022
Q1 | $191K | Hold |
25,221
| – | – | ﹤0.01% | 4258 |
|
2021
Q4 | $276K | Hold |
25,221
| – | – | ﹤0.01% | 4134 |
|
2021
Q3 | $326K | Buy |
+25,221
| New | +$326K | ﹤0.01% | 4005 |
|